Tredegar Reports Third Quarter 2020 Results
Tredegar Corporation (NYSE: TG) reported a third quarter 2020 net loss of $17 million ($0.51 per share), compared to net income of $15.1 million ($0.45 per share) in Q3 2019. Net income from ongoing operations was nearly flat at $13.2 million ($0.39 per share) versus $13.3 million ($0.40 per share) YoY. The Company completed the sale of its Personal Care Films business for $60.5 million. Key segments showed mixed results, with Aluminum Extrusions EBITDA stable at $16.5 million, while PE Films EBITDA decreased by $4.3 million. Cash flow improved significantly, reaching $28 million in excess of debt by Q3's end.
- Stable EBITDA for Aluminum Extrusions at $16.5 million, meeting expectations.
- Improved cash flow with net cash exceeding debt by $28 million as of September 30, 2020.
- Strong performance in Flexible Packaging Films with EBITDA doubling to $9.5 million YoY.
- Net loss of $17 million in Q3 2020 compared to a profit in Q3 2019.
- Decrease in PE Films segment EBITDA by 41.1% to $6 million due to product transition delays.
- Projected decline of up to $18 million in PE Films EBITDA due to customer product transitions in 2021.
RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Corporation (NYSE:TG, also the “Company” or “Tredegar”) today reported third quarter financial results for the period ended September 30, 2020.
Third quarter 2020 net loss from continuing operations was
On August 24, 2020, the Company entered into a definitive agreement to sell its Personal Care Films business ("Personal Care business"), which excludes the packaging film lines and related operations located at the Pottsville, Pennsylvania manufacturing site ("Pottsville Packaging"). The Company completed this divestiture at the end of October and received gross proceeds of
Third Quarter Financial Results Highlights
-
Earnings before interest, taxes, depreciation and amortization ("EBITDA") from ongoing operations for Aluminum Extrusions of
$16.5 million was$0.1 million higher than the third quarter of 2019 -
EBITDA from ongoing operations for PE Films of
$6.0 million was$4.2 million lower than the third quarter of 2019 -
EBITDA from ongoing operations for Flexible Packaging Films of
$9.5 million was$5.2 million higher than the third quarter of 2019
John Steitz, Tredegar’s president and chief executive officer said, “Despite COVID-19-related lower volume, Bonnell Aluminum's EBITDA from ongoing operations during the third quarter was essentially flat with last year. It continues to outperform our expectations. The PE Films segment experienced a decline in profitability during the third quarter versus last year due to previously disclosed customer product transitions in the Surface Protection component that had been delayed. Our Surface Protection team has been making progress in generating sales from new products, applications and customers to help offset the expected future adverse impact of the transitions. Regarding Terphane, our flexible packaging films business, its performance has been a great story since 2017, but especially in 2020 with EBITDA from ongoing operations doubling in 2020 versus 2019."
Mr. Steitz continued, "We had strong cash flow during the third quarter with net cash in excess of debt as of September 30, 2020 of
On a final note, Mr. Steitz commented, "I'd like to thank again all of our employees for their hard work and dedication during these unprecedented times."
THE IMPACT OF COVID-19
Essential Business and Employee Considerations
The Company’s priorities during the COVID-19 pandemic continue to be to protect the health and safety of employees while keeping its manufacturing sites open due to the essential nature of many of its products. The Company’s businesses have been deemed “essential services,” “critical manufacturers,” and “life sustaining industries” under applicable state or national stay-at-home orders and, therefore, remain operational. Within the limitations imposed by the health and safety procedures described below, the Company has continued to manufacture the full range of products at its facilities, including certain products that are components for end-uses that are essential, critical or life sustaining such as: (i) polyester-based materials for flexible food packaging, (ii) polyethylene-based film for packaging products, (iii) aluminum extrusion parts for hospital beds, FEMA tents, temporary hospital structures and medical equipment, (iv) materials for face shields, and (v) polyethylene-based films used to protect components of flat panel displays during manufacturing and transportation processes, which are instrumental to allowing employees to work from home.
The Company’s protocols to protect the health and well-being of its employees from COVID-19 continue to develop as COVID-19 informed work practices evolve and the Company responds to recommended and mandated actions of government and health authorities.
The Company has educated employees about COVID-19 symptoms and hygiene best practices. It has adopted COVID-19 related pay and sick leave policies that require employees to stay home if they feel ill or have been exposed to others with the illness, until they are released to return to work by our Human Resources team. The Company’s policies include taking an employee’s temperature before entering production facilities; answering self-screening questions related to potential exposure and COVID-19 symptoms; mandating handwashing; requiring social distancing, and requiring face coverings on production floors at all times, requiring face coverings in common areas and office settings where social distancing is difficult; streamlining onsite personnel to only those required for production and distribution; strongly encouraging and, where mandated, requiring remote work for all those who can work from home; and disinfecting facilities. In the U.S., the Company has educated employees on COVID-19-related government benefits.
In April 2020, the Company began providing a weekly dashboard to its Board of Directors highlighting the impacts of COVID-19 on its employees, businesses and financial condition.
As of November 4, the Company was aware that 202 of its employees have had confirmed cases of COVID-19 since the outbreak began, with no fatalities. 179 of those employees have returned to work. Additional employees have been absent or self-quarantined due to COVID-19. Bonnell Aluminum is experiencing higher than normal absenteeism and hiring difficulties which it attributes to COVID-19-related factors. Bonnell Aluminum continuously attempts to match its direct labor with demand and is facing difficulty hiring sufficient labor to meet desired shipment levels.
Financial Considerations
The 2020 annual plan for Bonnell Aluminum (pre-COVID-19) included sales volume of 201 million pounds and EBITDA from ongoing operations of
Approximately
Demand has remained strong under COVID-19 conditions for the Company’s flexible food packaging films produced by Terphane. The Surface Protection component of PE Films had record performance for EBITDA from ongoing operations in the second quarter and first half of 2020, but experienced a slowdown in the third quarter which it expects to continue for the fourth quarter of 2020, based on industry projections for products using flat panel displays and current customer inventory corrections. In addition, the Company estimates that a portion of the third quarter decline in volume for the Surface Protection business is related to a customer product transition previously disclosed (see the PE Films section of this report for further discussion). No significant issues have arisen to date on the collection of accounts receivable at Terphane or Surface Protection.
Tredegar’s defined benefit pension plan, which was frozen at the end of 2007, was underfunded on a GAAP basis by
Tredegar owns approximately
Tredegar had debt (all under its revolving credit agreement) of
CONTINUING OPERATIONS REVIEW
Aluminum Extrusions
Aluminum Extrusions, which is also referred to as Bonnell Aluminum, produces high-quality, soft-alloy and medium-strength aluminum extrusions primarily for the following markets: B&C, automotive, and specialty (which consists of consumer durables, machinery and equipment, electrical and distribution end-use products).
A summary of third quarter operating results for Aluminum Extrusions is provided below:
|
Three Months Ended |
|
Favorable/
|
|
Nine Months Ended |
|
Favorable/
|
||||||||||||||||||
(In thousands, except percentages) |
September 30, |
|
September 30, |
|
|||||||||||||||||||||
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
|
||||||||||||||
Sales volume (lbs) |
48,859 |
|
|
|
51,404 |
|
|
|
(5.0 |
)% |
|
139,985 |
|
|
|
158,657 |
|
|
|
(11.8 |
)% |
||||
Net sales |
$ |
115,621 |
|
|
|
$ |
129,505 |
|
|
|
(10.7 |
)% |
|
$ |
339,566 |
|
|
|
$ |
405,310 |
|
|
|
(16.2 |
)% |
Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
EBITDA |
$ |
16,540 |
|
|
|
$ |
16,464 |
|
|
|
0.5 |
% |
|
$ |
41,496 |
|
|
|
$ |
51,231 |
|
|
|
(19.0 |
)% |
Depreciation & amortization* |
$ |
(4,251 |
) |
|
|
$ |
(4,317 |
) |
|
|
1.5 |
% |
|
$ |
(12,632 |
) |
|
|
$ |
(12,481 |
) |
|
|
(1.2 |
)% |
EBIT** |
$ |
12,289 |
|
|
|
$ |
12,147 |
|
|
|
1.2 |
% |
|
$ |
28,864 |
|
|
|
$ |
38,750 |
|
|
|
(25.5 |
)% |
Capital expenditures |
$ |
1,784 |
|
|
|
$ |
3,057 |
|
|
|
|
|
$ |
4,713 |
|
|
|
$ |
11,844 |
|
|
|
|
||
*Excludes pre-tax accelerated amortization of trade name of |
|||||||||||||||||||||||||
**See the net sales and EBITDA from ongoing operations by segment statements for a reconciliation of this non-GAAP measure to GAAP. |
Third Quarter 2020 Results vs. Third Quarter 2019 Results
Net sales (sales less freight) in the third quarter of 2020 decreased versus 2019 primarily due to lower sales volume and the pass-through of lower metal costs, partially offset by an increase in average selling prices to cover higher operating costs. Sales volume in the third quarter of 2020 decreased by
EBITDA from ongoing operations in the third quarter of 2020 was relatively flat in comparison to the third quarter of 2019. Lower volumes (
First Nine Months 2020 Results vs. First Nine Months 2019 Results
Net sales in the first nine months of 2020 decreased versus 2019 primarily due to lower sales volume and the pass-through of lower metal costs, partially offset by an increase in average selling prices to cover higher operating costs. Sales volume in the first nine months of 2020 decreased by
EBITDA from ongoing operations in the first nine months of 2020 decreased in comparison to the first nine months of 2019 due to lower volumes (
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for Bonnell Aluminum are projected to be
PE Films
PE Films is composed of surface protection films, polyethylene overwrap films and films for other markets. All historical results for the Personal Care business have been presented as discontinued operations. The surface protection component of the PE Films segment now includes Pottsville Packaging. A summary of third quarter operating results for PE Films is provided below:
|
Three Months Ended |
|
Favorable/
|
|
Nine Months Ended |
|
Favorable/
|
||||||||||||||||||
(In thousands, except percentages) |
September 30, |
|
September 30, |
|
|||||||||||||||||||||
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
|
||||||||||||||
Sales volume (lbs) |
9,556 |
|
|
|
11,132 |
|
|
|
(14.2 |
)% |
|
33,348 |
|
|
|
31,936 |
|
|
|
4.4 |
% |
||||
Net sales |
$ |
26,440 |
|
|
|
$ |
34,487 |
|
|
|
(23.3 |
)% |
|
$ |
103,444 |
|
|
|
$ |
99,313 |
|
|
|
4.2 |
% |
Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
EBITDA |
$ |
6,041 |
|
|
|
$ |
10,257 |
|
|
|
(41.1 |
)% |
|
$ |
33,928 |
|
|
|
$ |
30,452 |
|
|
|
11.4 |
% |
Depreciation & amortization |
$ |
(1,785 |
) |
|
|
$ |
(1,458 |
) |
|
|
(22.4 |
)% |
|
$ |
(4,868 |
) |
|
|
$ |
(4,380 |
) |
|
|
(11.1 |
)% |
EBIT* |
$ |
4,256 |
|
|
|
$ |
8,799 |
|
|
|
(51.6 |
)% |
|
$ |
29,060 |
|
|
|
$ |
26,072 |
|
|
|
11.5 |
% |
Capital expenditures |
$ |
187 |
|
|
|
$ |
3,623 |
|
|
|
|
|
$ |
3,231 |
|
|
|
$ |
5,575 |
|
|
|
|
||
* See the net sales and EBITDA from ongoing operations by segment statements for a reconciliation of this non-GAAP measure to GAAP. |
Third Quarter 2020 Results vs. Third Quarter 2019 Results
Net sales declined by
EBITDA from ongoing operations in the third quarter of 2020 decreased by
Customer Product Transitions in Surface Protection
The Surface Protection component of PE Films supports manufacturers of optical and other specialty substrates used in flat panel display products. These films are primarily used by customers to protect components of displays in the manufacturing and transportation processes and then discarded.
The Company previously reported the risk that a portion of its film products used in surface protection applications will be made obsolete by possible future customer product transitions to less costly alternative processes or materials. These transitions principally relate to one customer. The Company believes that previously reported delays in this customer's transitions were recently resolved by the customer and much of the remaining transitions could occur by the end of 2021. Under this scenario, the Company estimates that the contribution to EBITDA from ongoing operations for PE Films could decline due to the remaining customer product transitions by
First Nine Months 2020 Results vs. First Nine Months 2019 Results
Net sales increased by
EBITDA from ongoing operations in the first nine months of 2020 increased by
-
A
$1.9 million increase from Surface Protection, primarily due to sales of products unrelated to the customer product transitions ($3.7 million ), partially offset by lower sales associated with the customer product transitions that occurred during the third quarter of this year ($1.3 million ) and higher net manufacturing operating costs and selling, general and administrative expenses ($0.5 million ); and -
A
$1.2 million increase from Pottsville Packaging primarily related to higher sales volume and a$0.4 million favorable variance from other activities.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for PE Films are projected to be
Flexible Packaging Films
Flexible Packaging Films, which is also referred to as Terphane, produces polyester-based films for use in packaging applications that have specialized properties, such as heat resistance, strength, barrier protection and the ability to accept high-quality print graphics. A summary of third quarter operating results for Flexible Packaging Films is provided below:
|
Three Months Ended |
|
Favorable/
|
|
Nine Months Ended |
|
Favorable/
|
||||||||||||||||||
(In thousands, except percentages) |
September 30, |
|
September 30, |
|
|||||||||||||||||||||
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
|
||||||||||||||
Sales volume (lbs) |
30,115 |
|
|
|
27,920 |
|
|
|
7.9 |
% |
|
85,089 |
|
|
|
79,841 |
|
|
|
6.6 |
% |
||||
Net sales |
$ |
35,856 |
|
|
|
$ |
34,888 |
|
|
|
2.8 |
% |
|
$ |
100,534 |
|
|
|
$ |
101,950 |
|
|
|
(1.4 |
)% |
Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
EBITDA |
$ |
9,546 |
|
|
|
$ |
4,394 |
|
|
|
117.3 |
% |
|
$ |
22,594 |
|
|
|
$ |
10,477 |
|
|
|
115.7 |
% |
Depreciation & amortization |
$ |
(443 |
) |
|
|
$ |
(394 |
) |
|
|
(12.4 |
)% |
|
$ |
(1,306 |
) |
|
|
$ |
(1,101 |
) |
|
|
(18.6 |
)% |
EBIT* |
$ |
9,103 |
|
|
|
$ |
4,000 |
|
|
|
127.6 |
% |
|
$ |
21,288 |
|
|
|
$ |
9,376 |
|
|
|
127.0 |
% |
Capital expenditures |
$ |
1,183 |
|
|
|
$ |
2,698 |
|
|
|
|
|
$ |
2,448 |
|
|
|
$ |
5,692 |
|
|
|
|
||
* See the net sales and EBITDA from ongoing operations by segment statements for a reconciliation of this non-GAAP measure to GAAP. |
Third Quarter 2020 Results vs. Third Quarter 2019 Results
Net sales in the third quarter of 2020 increased
Terphane’s EBITDA from ongoing operations in the third quarter of 2020 increased by
-
Lower raw material costs, net of lower selling prices (
$0.9 million ), higher sales volume ($0.9 million ), favorable product mix ($1.0 million ), and lower fixed ($1.2 million ) and variable costs ($0.4 million ); -
Net favorable foreign currency translation of Real-denominated operating costs (
$0.6 million ); and -
Foreign currency transaction gains of
$0.5 million in 2020 versus gains of$0.3 million in 2019.
Terphane has experienced strong demand in all of its markets, including Brazil, North America and export markets, and especially in the U.S. for value-added products, driven by the need for safe packaged food and cleaning products during the COVID-19 environment. See the “The Impact of COVID-19” section for more information.
First Nine Months 2020 Results vs. First Nine Months 2019 Results
Net sales in the first nine months of 2020 decreased
Terphane’s EBITDA from ongoing operations in the first nine months of 2020 increased by
-
Lower raw material costs, net of lower selling prices (
$5.6 million ), higher sales volume ($2.2 million ), favorable product mix ($1.8 million ), lower fixed costs ($1.3 million ), partially offset by higher variable costs ($1.1 million ); -
Net favorable foreign currency translation of Real-denominated costs (
$1.2 million ); -
Foreign currency transaction gains of
$0.2 million in the first nine months of 2020 versus transaction gains of$0.3 million in 2019; and -
A benefit of
$1.2 million in the first three months of 2020 resulting from the favorable settlement of a dispute related to value-added taxes.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for Flexible Packaging Films are projected to be
Corporate Expenses, Interest, Taxes & Other
Pension expense was
Interest expense was
The effective tax rate used to compute income tax expense from continuing operations was
FORWARD-LOOKING AND CAUTIONARY STATEMENTS
Some of the information contained in this press release may constitute “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. When the Company uses the words “believe,” “estimate,” “anticipate,” “appear to,” “expect,” “project,” “plan,” “likely,” “may” and similar expressions, it does so to identify forward-looking statements. Such statements are based on the Company's then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in or implied by these forward-looking statements. In addition, the Company's current projections for its businesses could be materially affected by the highly uncertain impact of COVID-19. As a consequence, the Company's results could differ significantly from its projections, depending on, among other things, the duration of "shelter in place" orders and the ultimate impact of the pandemic on employees, supply chains, customers and the U.S. and world economies. Accordingly, you should not place undue reliance on these forward-looking statements. Factors that could cause actual results to differ from expectations include, without limitation, the following:
- loss or gain of sales to significant customers on which the Company's business is highly dependent;
- inability to achieve sales to new customers to replace lost business;
- inability to develop, efficiently manufacture and deliver new products at competitive prices;
- failure of the Company's customers to achieve success or maintain market share;
- failure to protect our intellectual property rights;
- risks of doing business in countries outside the U.S. that affect our substantial international operations;
- political, economic, and regulatory factors concerning the Company's products;
- uncertain economic conditions in countries in which the Company does business;
- competition from other manufacturers, including manufacturers in lower-cost countries and manufacturers benefiting from government subsidies;
- impact of fluctuations in foreign exchange rates;
- a change in the amount of the Company's underfunded defined benefit pension plan liability;
- an increase in the operating costs incurred by the Company's business units, including, for example, the cost of raw materials and energy;
- inability to successfully identify, complete or integrate strategic acquisitions; failure to realize the expected benefits of such acquisitions and assumption of unanticipated risks in such acquisitions;
- disruption to the Company's manufacturing facilities;
- the impact of public health epidemics on employees, production and the global economy, such as the coronavirus (COVID-19) currently impacting the global economy;
- an information technology system failure or breach;
- volatility and uncertainty of the valuation of the Company's investment in kaléo;
- the impact of the imposition of tariffs and sanctions on imported aluminum ingot used by Bonnell Aluminum;
- the impact of new tariffs, duties or other trade restrictions imposed as a result of rising trade tensions between the U.S. and other countries;
- the termination of anti-dumping duties on products imported to Brazil that compete with products produced by Flexible Packaging;
- failure to establish and maintain effective internal control over financial reporting;
and the other factors discussed in the reports Tredegar files with or furnishes to the Securities and Exchange Commission (the “SEC”) from time to time, including the risks and important factors set forth in additional detail in Part I, Item 1A of Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2019 and Quarterly Report on Form 10-Q for the period ended March 31, 2020. Readers are urged to review and consider carefully the disclosures Tredegar makes in its filings with the SEC.
Tredegar does not undertake, and expressly disclaims any duty, to update any forward-looking statement made in this press release to reflect any change in management’s expectations or any change in conditions, assumptions or circumstances on which such statements are based, except as required by applicable law.
To the extent that the financial information portion of this press release contains non-GAAP financial measures, it also presents both the most directly comparable financial measures calculated and presented in accordance with GAAP and a quantitative reconciliation of the difference between any such non-GAAP measures and such comparable GAAP financial measures. Reconciliations of non-GAAP financial measures are provided in the Notes to the Financial Tables included with this press release and can also be found within “Presentations” in the “Investors” section of our website, www.tredegar.com.
Tredegar uses its website as a channel of distribution of material Company information. Financial information and other material information regarding Tredegar is posted on and assembled in the “Investors” section of its website.
Tredegar Corporation is an industrial manufacturer with three primary businesses: custom aluminum extrusions for the North American building & construction, automotive and specialty end-use markets; surface protection films for high-technology applications in the global electronics industry; and specialized polyester films primarily for the Latin American flexible packaging market. Tredegar had 2019 sales from continuing operations of
Tredegar Corporation |
||||||||||||||||
Condensed Consolidated Statements of Income |
||||||||||||||||
(In Thousands, Except Per-Share Data) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
|
|
|
|
|
||||||||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
|
September 30, |
|
September 30, |
||||||||||||
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||
Sales |
|
$ |
184,370 |
|
|
$ |
205,968 |
|
|
$ |
562,766 |
|
|
$ |
628,011 |
|
Other income (expense), net (c)(d) |
|
(37,934) |
|
|
4,272 |
|
|
(63,898) |
|
|
28,508 |
|
||||
|
|
146,436 |
|
|
210,240 |
|
|
498,868 |
|
|
656,519 |
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Cost of goods sold (c) |
|
136,008 |
|
|
159,989 |
|
|
415,212 |
|
|
488,320 |
|
||||
Freight |
|
6,453 |
|
|
7,088 |
|
|
19,222 |
|
|
21,438 |
|
||||
Selling, R&D and general expenses (c) |
|
22,076 |
|
|
21,162 |
|
|
67,717 |
|
|
62,350 |
|
||||
Amortization of intangibles |
|
753 |
|
|
3,400 |
|
|
2,264 |
|
|
5,182 |
|
||||
Pension and postretirement benefits |
|
3,567 |
|
|
2,415 |
|
|
10,701 |
|
|
7,246 |
|
||||
Interest expense |
|
494 |
|
|
859 |
|
|
1,598 |
|
|
3,354 |
|
||||
Asset impairments and costs associated with exit and disposal activities, net of adjustments (c) |
|
3 |
|
|
98 |
|
|
74 |
|
|
608 |
|
||||
Goodwill impairment (e) |
|
— |
|
|
— |
|
|
13,696 |
|
|
— |
|
||||
|
|
169,354 |
|
|
195,011 |
|
|
530,484 |
|
|
588,498 |
|
||||
Income (loss) from continuing operations before income taxes |
|
(22,918) |
|
|
15,229 |
|
|
(31,616) |
|
|
68,021 |
|
||||
Income tax expense (benefit) |
|
(5,942) |
|
|
177 |
|
|
(8,308) |
|
|
10,550 |
|
||||
Net income (loss) from continuing operations |
|
(16,976) |
|
|
15,052 |
|
|
(23,308) |
|
|
57,471 |
|
||||
Income (loss) from discontinued operations, net of tax |
|
(48,237) |
|
|
2,081 |
|
|
(53,031) |
|
|
(6,076) |
|
||||
Net income (loss) |
|
$ |
(65,213) |
|
|
$ |
17,133 |
|
|
$ |
(76,339) |
|
|
$ |
51,395 |
|
|
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
Basic: |
|
|
|
|
|
|
|
|
||||||||
Continuing operations |
|
$ |
(0.51) |
|
|
$ |
0.45 |
|
|
$ |
(0.70) |
|
|
$ |
1.73 |
|
Discontinued operations |
|
(1.44) |
|
|
0.06 |
|
|
(1.59) |
|
|
(0.18) |
|
||||
Basic earnings (loss) per share |
|
$ |
(1.95) |
|
|
$ |
0.51 |
|
|
$ |
(2.29) |
|
|
$ |
1.55 |
|
Diluted: |
|
|
|
|
|
|
|
|
||||||||
Continuing operations |
|
$ |
(0.51) |
|
|
$ |
0.45 |
|
|
$ |
(0.70) |
|
|
$ |
1.73 |
|
Discontinued operations |
|
(1.44) |
|
|
0.06 |
|
|
(1.59) |
|
|
(0.18) |
|
||||
Diluted earnings (loss) per share |
|
$ |
(1.95) |
|
|
$ |
0.51 |
|
|
$ |
(2.29) |
|
|
$ |
1.55 |
|
|
|
|
|
|
|
|
|
|
||||||||
Shares used to compute earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
Basic |
|
33,439 |
|
|
33,271 |
|
|
33,396 |
|
|
33,222 |
|
||||
Diluted |
|
33,439 |
|
|
33,285 |
|
|
33,396 |
|
|
33,230 |
|
Tredegar Corporation |
|||||||||||||||
Net Sales and EBITDA from Ongoing Operations by Segment |
|||||||||||||||
(In Thousands) |
|||||||||||||||
(Unaudited) |
|||||||||||||||
|
|
|
|
||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
September 30, |
|
September 30, |
||||||||||||
|
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||
Net Sales |
|
|
|
|
|
|
|
||||||||
Aluminum Extrusions |
$ |
115,621 |
|
|
$ |
129,505 |
|
|
$ |
339,566 |
|
|
$ |
405,310 |
|
PE Films |
26,440 |
|
|
34,487 |
|
|
103,444 |
|
|
99,313 |
|
||||
Flexible Packaging Films |
35,856 |
|
|
34,888 |
|
|
100,534 |
|
|
101,950 |
|
||||
Total net sales |
177,917 |
|
|
198,880 |
|
|
543,544 |
|
|
606,573 |
|
||||
Add back freight |
6,453 |
|
|
7,088 |
|
|
19,222 |
|
|
21,438 |
|
||||
Sales as shown in the Condensed Consolidated Statements of Income |
$ |
184,370 |
|
|
$ |
205,968 |
|
|
$ |
562,766 |
|
|
$ |
628,011 |
|
EBITDA from Ongoing Operations |
|
|
|
|
|
|
|
||||||||
Aluminum Extrusions: |
|
|
|
|
|
|
|
||||||||
Ongoing operations: |
|
|
|
|
|
|
|
||||||||
EBITDA (b) |
$ |
16,540 |
|
|
$ |
16,464 |
|
|
$ |
41,496 |
|
|
$ |
51,231 |
|
Depreciation & amortization |
(4,251) |
|
|
(4,317) |
|
|
(12,632) |
|
|
(12,481) |
|
||||
EBIT (b) |
12,289 |
|
|
12,147 |
|
|
28,864 |
|
|
38,750 |
|
||||
Plant shutdowns, asset impairments, restructurings and other (c) |
(720) |
|
|
(610) |
|
|
(2,637) |
|
|
(667) |
|
||||
Goodwill impairment (e) |
— |
|
|
— |
|
|
(13,696) |
|
|
— |
|
||||
Trade name accelerated amortization (g) |
— |
|
|
(2,510) |
|
|
— |
|
|
(2,510) |
|
||||
PE Films: |
|
|
|
|
|
|
|
||||||||
Ongoing operations: |
|
|
|
|
|
|
|
||||||||
EBITDA (b) |
6,041 |
|
|
10,257 |
|
|
33,928 |
|
|
30,452 |
|
||||
Depreciation & amortization |
(1,785) |
|
|
(1,458) |
|
|
(4,868) |
|
|
(4,380) |
|
||||
EBIT (b) |
4,256 |
|
|
8,799 |
|
|
29,060 |
|
|
26,072 |
|
||||
Plant shutdowns, asset impairments, restructurings and other (c) |
(56) |
|
|
(60) |
|
|
(225) |
|
|
(555) |
|
||||
Flexible Packaging Films: |
|
|
|
|
|
|
|
||||||||
Ongoing operations: |
|
|
|
|
|
|
|
||||||||
EBITDA (b) |
9,546 |
|
|
4,394 |
|
|
22,594 |
|
|
10,477 |
|
||||
Depreciation & amortization |
(443) |
|
|
(394) |
|
|
(1,306) |
|
|
(1,101) |
|
||||
EBIT (b) |
9,103 |
|
|
4,000 |
|
|
21,288 |
|
|
9,376 |
|
||||
Plant shutdowns, asset impairments, restructurings and other (c) |
(3) |
|
|
— |
|
|
(14) |
|
|
— |
|
||||
Total |
24,869 |
|
|
21,766 |
|
|
62,640 |
|
|
70,466 |
|
||||
Interest income |
11 |
|
|
11 |
|
|
43 |
|
|
25 |
|
||||
Interest expense |
494 |
|
|
859 |
|
|
1,598 |
|
|
3,354 |
|
||||
Gain (loss) on investment in kaléo accounted for under fair value method (d) |
(36,200) |
|
|
4,300 |
|
|
(61,000) |
|
|
28,482 |
|
||||
Stock option-based compensation costs |
518 |
|
|
791 |
|
|
1,786 |
|
|
2,060 |
|
||||
Corporate expenses, net (c) |
10,586 |
|
|
9,198 |
|
|
29,915 |
|
|
25,538 |
|
||||
Income (loss) from continuing operations before income taxes |
(22,918) |
|
|
15,229 |
|
|
(31,616) |
|
|
68,021 |
|
||||
Income tax expense (benefit) |
(5,942) |
|
|
177 |
|
|
(8,308) |
|
|
10,550 |
|
||||
Net income (loss) from continuing operations |
(16,976) |
|
|
15,052 |
|
|
(23,308) |
|
|
57,471 |
|
||||
Net income (loss) from discontinued operations, net of tax |
(48,237) |
|
|
2,081 |
|
|
(53,031) |
|
|
(6,076) |
|
||||
Net income (loss) |
$ |
(65,213) |
|
|
$ |
17,133 |
|
|
$ |
(76,339) |
|
|
$ |
51,395 |
|
Tredegar Corporation |
||||||||
Condensed Consolidated Balance Sheets |
||||||||
(In Thousands) |
||||||||
(Unaudited) |
||||||||
|
|
|
|
|
||||
|
|
September 30, 2020 |
|
December 31, 2019 |
||||
Assets |
|
|
|
|
||||
Cash & cash equivalents |
|
$ |
35,022 |
|
|
$ |
31,422 |
|
Accounts & other receivables, net |
|
82,089 |
|
|
89,117 |
|
||
Income taxes recoverable |
|
58 |
|
|
2,661 |
|
||
Inventories |
|
63,543 |
|
|
64,205 |
|
||
Prepaid expenses & other |
|
13,421 |
|
|
8,333 |
|
||
Current assets of discontinued operations |
|
45,955 |
|
|
37,418 |
|
||
Total current assets |
|
240,088 |
|
|
233,156 |
|
||
Property, plant & equipment, net |
|
164,940 |
|
|
173,556 |
|
||
Right-of-use leased assets |
|
16,965 |
|
|
18,492 |
|
||
Investment in kaléo (cost basis of |
|
34,500 |
|
|
95,500 |
|
||
Identifiable intangible assets, net |
|
19,985 |
|
|
22,636 |
|
||
Goodwill |
|
67,708 |
|
|
81,404 |
|
||
Deferred income taxes |
|
19,761 |
|
|
12,435 |
|
||
Other assets |
|
3,693 |
|
|
4,628 |
|
||
Non-current assets of discontinued operations |
|
— |
|
|
70,861 |
|
||
Total assets |
|
$ |
567,640 |
|
|
$ |
712,668 |
|
Liabilities and Shareholders’ Equity |
|
|
|
|
||||
Accounts payable |
|
$ |
76,049 |
|
|
$ |
87,296 |
|
Accrued expenses |
|
44,582 |
|
|
39,465 |
|
||
Lease liability, short-term |
|
2,705 |
|
|
2,427 |
|
||
Income taxes payable |
|
2,296 |
|
|
— |
|
||
Current liabilities of discontinued operations |
|
21,333 |
|
|
23,280 |
|
||
Total current liabilities |
|
146,965 |
|
|
152,468 |
|
||
Lease liability, long-term |
|
15,583 |
|
|
17,338 |
|
||
Long-term debt |
|
7,000 |
|
|
42,000 |
|
||
Pension and other postretirement benefit obligations, net |
|
104,563 |
|
|
107,446 |
|
||
Deferred income taxes |
|
— |
|
|
11,019 |
|
||
Other non-current liabilities |
|
4,220 |
|
|
5,297 |
|
||
Non-current liabilities of discontinued operations |
|
— |
|
|
351 |
|
||
Shareholders’ equity |
|
289,309 |
|
|
376,749 |
|
||
Total liabilities and shareholders’ equity |
|
$ |
567,640 |
|
|
$ |
712,668 |
|
Tredegar Corporation |
||||||||
Condensed Consolidated Statements of Cash Flows |
||||||||
(In Thousands) |
||||||||
(Unaudited) |
||||||||
|
|
|
||||||
|
|
Nine Months Ended September 30, |
||||||
|
|
2020 |
|
2019 |
||||
Cash flows from operating activities: |
|
|
|
|
||||
Net income (loss) |
|
$ |
(76,339) |
|
|
$ |
51,395 |
|
Adjustments for noncash items: |
|
|
|
|
||||
Depreciation |
|
23,218 |
|
|
22,572 |
|
||
Amortization of intangibles |
|
2,264 |
|
|
5,182 |
|
||
Reduction of right-of-use lease asset |
|
2,102 |
|
|
1,899 |
|
||
Goodwill impairment |
|
13,696 |
|
|
— |
|
||
Deferred income taxes |
|
(19,492) |
|
|
7,404 |
|
||
Accrued pension income and post-retirement benefits |
|
10,701 |
|
|
7,246 |
|
||
(Gain) loss on investment accounted for under the fair value method |
|
61,000 |
|
|
(10,900) |
|
||
Held for sale impairment loss on divested assets |
|
45,054 |
|
|
— |
|
||
Net gain on sale of assets |
|
— |
|
|
(6,328) |
|
||
Changes in assets and liabilities: |
|
|
|
|
||||
Accounts and other receivables |
|
4,961 |
|
|
7,715 |
|
||
Inventories |
|
(2,761) |
|
|
6,625 |
|
||
Income taxes recoverable/payable |
|
5,332 |
|
|
1,439 |
|
||
Prepaid expenses and other |
|
(5,305) |
|
|
14 |
|
||
Accounts payable and accrued expenses |
|
(2,112) |
|
|
(223) |
|
||
Lease liability |
|
(2,245) |
|
|
(1,991) |
|
||
Pension and postretirement benefit plan contributions |
|
(2,254) |
|
|
(6,692) |
|
||
Other, net |
|
8,506 |
|
|
966 |
|
||
Net cash provided by operating activities |
|
66,326 |
|
|
86,323 |
|
||
Cash flows from investing activities: |
|
|
|
|
||||
Capital expenditures |
|
(13,416) |
|
|
(37,214) |
|
||
Proceeds from the sale of assets and other |
|
— |
|
|
10,931 |
|
||
Net cash used in investing activities |
|
(13,416) |
|
|
(26,283) |
|
||
Cash flows from financing activities: |
|
|
|
|
||||
Borrowings |
|
25,000 |
|
|
53,000 |
|
||
Debt principal payments |
|
(60,000) |
|
|
(86,500) |
|
||
Dividends paid |
|
(12,048) |
|
|
(11,322) |
|
||
Debt financing costs |
|
— |
|
|
(1,817) |
|
||
Repurchase of employee common stock for tax withholdings |
|
(586) |
|
|
(854) |
|
||
Net cash used in financing activities |
|
(47,634) |
|
|
(47,493) |
|
||
Effect of exchange rate changes on cash |
|
(1,676) |
|
|
(2,292) |
|
||
Increase in cash and cash equivalents |
|
3,600 |
|
|
10,255 |
|
||
Cash and cash equivalents at beginning of period |
|
31,422 |
|
|
34,397 |
|
||
Cash and cash equivalents at end of period |
|
$ |
35,022 |
|
|
$ |
44,652 |
|
Notes to the Financial Tables (Unaudited) |
||
(a) | Tredegar’s presentation of net income (loss) and diluted earnings per share from ongoing operations are non-GAAP financial measures that exclude the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges, discontinued operations and other items (which includes unrealized gains and losses for an investment accounted for under the fair value method) which have been presented separately and removed from net income (loss) from continuing operations and diluted earnings per share as reported under GAAP. Net income and diluted earnings (loss) per share from ongoing operations are key financial and analytical measures used by management to gauge the operating performance of Tredegar’s ongoing operations. They are not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) from continuing operations or earnings (loss) per share as defined by GAAP. They exclude items that management believes do not relate to Tredegar’s ongoing operations. A reconciliation to net income (loss) and diluted earnings (loss) per share from ongoing operations for the three and nine months ended September 30, 2020 and 2019 is shown below: |
(in millions, except per share data) |
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
Net income (loss) from continuing operations as reported under GAAP |
|
$ |
(17.0) |
|
|
$ |
15.1 |
|
|
$ |
(23.3) |
|
|
$ |
57.5 |
|
After-tax effects of: |
|
|
|
|
|
|
|
|
||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
— |
|
|
0.1 |
|
|
0.1 |
|
|
0.5 |
|
||||
(Gains) losses from sale of assets and other: |
|
|
|
|
|
|
|
|
||||||||
(Gain) loss associated with the investment in kaléo |
|
28.2 |
|
|
(3.4) |
|
|
47.7 |
|
|
(23.3) |
|
||||
Other |
|
2.0 |
|
|
1.5 |
|
|
6.1 |
|
|
2.9 |
|
||||
Goodwill impairment |
|
— |
|
|
— |
|
|
10.5 |
|
|
— |
|
||||
Net income (loss) from ongoing operations |
|
$ |
13.2 |
|
|
$ |
13.3 |
|
|
$ |
41.1 |
|
|
$ |
37.6 |
|
|
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) from continuing operations per share as reported under GAAP (diluted) |
|
$ |
(0.51) |
|
|
$ |
0.45 |
|
|
$ |
(0.70) |
|
|
$ |
1.73 |
|
After-tax effects per diluted share of: |
|
|
|
|
|
|
|
|
||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
— |
|
|
— |
|
|
— |
|
|
0.01 |
|
||||
(Gains) losses from sale of assets and other: |
|
|
|
|
|
|
|
|
||||||||
(Gain) loss associated with the investment in kaléo |
|
0.84 |
|
|
(0.10) |
|
|
1.43 |
|
|
(0.71) |
|
||||
Other |
|
0.06 |
|
|
0.05 |
|
|
0.17 |
|
|
0.09 |
|
||||
Goodwill impairment |
|
— |
|
|
— |
|
|
0.32 |
|
|
— |
|
||||
Earnings (loss) per share from ongoing operations (diluted) |
|
$ |
0.39 |
|
|
$ |
0.40 |
|
|
$ |
1.22 |
|
|
$ |
1.12 |
|
Reconciliations of the pre-tax and post-tax balances attributed to net income are shown in Note (f). |
(b) | EBITDA (earnings before interest, taxes, depreciation and amortization) from ongoing operations is the key profitability metric used by the Company’s chief operating decision maker to assess segment financial performance. For more business segment information, see Note 11 in the Notes to Financial Statements in the Form 10-Q for the quarter ended September 30, 2020. |
|
EBIT (earnings before interest and taxes) from ongoing operations is a non-GAAP financial measure included in the accompanying tables and the reconciliation of segment financial information to consolidated results for the Company in the net sales and EBITDA from ongoing operations by segment statements. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) as defined by GAAP. EBIT is a widely understood and utilized metric that is meaningful to certain investors. The Company believes that including this financial metric in the reconciliation of management’s performance metric, EBITDA from ongoing operations, provides useful information to those investors that primarily utilize EBIT to analyze the Company’s core operations. |
||
(c) | Losses associated with plant shutdowns, asset impairments, restructurings and other items for the three and nine months ended September 30, 2020 and 2019 detailed below are shown in the statements of net sales and EBITDA from ongoing operations by segment and are included in “Asset impairments and costs associated with exit and disposal activities, net of adjustments” in the condensed consolidated statements of income, unless otherwise noted. |
|
Three Months Ended September 30, 2020 |
Nine Months Ended September 30, 2020 |
||||||||||
($ in millions) |
Pre-Tax |
Net of Tax |
Pre-Tax |
Net of Tax |
||||||||
Aluminum Extrusions: |
|
|
|
|
||||||||
Losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||
Consulting expenses for ERP feasibility study1 |
$ |
0.3 |
|
$ |
0.2 |
|
$ |
1.2 |
|
$ |
0.9 |
|
COVID-19-related expenses2 |
0.5 |
|
0.4 |
|
1.4 |
|
1.1 |
|
||||
Total for Aluminum Extrusions |
$ |
0.8 |
|
$ |
0.6 |
|
$ |
2.6 |
|
$ |
2.0 |
|
PE Films: |
|
|
|
|
||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: |
|
|
|
|
||||||||
Other restructuring costs - severance |
$ |
— |
|
$ |
— |
|
$ |
0.1 |
|
$ |
— |
|
Losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||
COVID-19-related expenses2 |
— |
|
— |
|
0.2 |
|
0.1 |
|
||||
Total for PE Films |
$ |
— |
|
$ |
— |
|
$ |
0.3 |
|
$ |
0.1 |
|
Corporate: |
|
|
|
|
||||||||
Professional fees associated with: remediation activities and other costs relating to the Company’s material weaknesses in internal control over financial reporting; business development activities; and implementation of new accounting guidance1 |
$ |
0.6 |
|
$ |
0.4 |
|
$ |
4.1 |
|
$ |
3.2 |
|
Accelerated recognition of stock-based compensation expense1 |
— |
|
— |
|
0.1 |
|
0.1 |
|
||||
Corporate costs associated with the divested Personal Care business1 |
1.1 |
|
0.9 |
|
1.1 |
|
0.9 |
|
||||
Write-down of investment in Harbinger Capital Partners Special Situations Fund2 |
0.1 |
|
0.1 |
|
0.3 |
|
0.2 |
|
||||
U.S. tax on foreign branch income3 |
— |
|
— |
|
— |
|
(0.6) |
|
||||
Total for Corporate |
$ |
1.8 |
|
$ |
1.4 |
|
$ |
5.6 |
|
$ |
3.8 |
|
|
|
Three Months Ended September 30, 2019 |
Nine Months Ended September 30, 2019 |
|||||||||||
($ in millions) |
Pre-Tax |
Net of Tax |
Pre-Tax |
Net of Tax |
||||||||
Aluminum Extrusions: |
|
|
|
|
||||||||
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||
Wind damage to roof of Elkhart, Indiana plant2 |
$ |
0.3 |
|
$ |
0.2 |
|
$ |
0.3 |
|
$ |
0.2 |
|
Environmental charges at Carthage, Tennessee plant1 |
0.3 |
|
0.2 |
|
0.3 |
|
0.3 |
|
||||
Total for Aluminum Extrusions |
$ |
0.6 |
|
$ |
0.4 |
|
$ |
0.6 |
|
$ |
0.5 |
|
PE Films: |
|
|
|
|
||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: |
|
|
|
|
||||||||
Write-off of films production line - Guangzhou, China facility |
$ |
— |
|
$ |
— |
|
$ |
0.4 |
|
$ |
0.3 |
|
Other restructuring costs - severance |
0.1 |
|
— |
|
0.1 |
|
0.1 |
|
||||
Total for PE Films |
$ |
0.1 |
|
$ |
— |
|
$ |
0.5 |
|
$ |
0.4 |
|
Corporate: |
|
|
|
|
||||||||
Professional fees associated with: remediation activities and other costs relating to the Company’s material weaknesses in internal control over financial reporting; business development activities; and implementation of new accounting guidance2 |
$ |
1.5 |
|
$ |
1.2 |
|
$ |
3.3 |
|
$ |
2.6 |
|
Tax adjustment - FIN 48 reserve reversal3 |
— |
|
(2.0) |
|
— |
|
(2.0) |
|
||||
Total for Corporate |
$ |
1.5 |
|
$ |
(0.8) |
|
$ |
3.3 |
|
$ |
0.6 |
|
|
(d) |
A loss on the Company’s investment in kaléo of |
|
(e) |
In the first quarter of 2020, the operations of Aluminum Extrusions’ Niles, Michigan and Elkhart, Indiana facilities (which were acquired as “AACOA” in October 2012) was expected to be severely impacted by the COVID-19 pandemic, with over |
|
(f) |
Tredegar’s presentation of net income (loss) from ongoing operations is a non-GAAP financial measure that excludes the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges, discontinued operations, and other items (which includes unrealized gains and losses for an investment accounted for under the fair value method), which has been presented separately and removed from net income (loss) as reported under GAAP. Net income (loss) from ongoing operations is a key financial and analytical measure used by management to gauge the operating performance of Tredegar’s ongoing operations. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) as defined by GAAP. It excludes items that we believe do not relate to Tredegar’s ongoing operations. |
Reconciliations of the pre-tax and post-tax balances attributed to net income (loss) from ongoing operations for the three and nine months ended September 30, 2020 and 2019 are shown below in order to show the impact on the effective tax rate:
(in millions) |
Pre-tax |
|
Tax Expense
|
|
After-
|
|
Effective
|
|||||||
Three Months Ended September 30, 2020 |
(a) |
|
(b) |
|
|
|
(b)/(a) |
|||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
(22.9) |
|
|
$ |
(5.9) |
|
|
$ |
(17.0) |
|
|
25.8 |
% |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
— |
|
|
— |
|
|
— |
|
|
|
||||
(Gains) losses from sale of assets and other |
38.8 |
|
|
8.6 |
|
|
30.2 |
|
|
|
||||
Net income (loss) from ongoing operations |
$ |
15.9 |
|
|
$ |
2.7 |
|
|
$ |
13.2 |
|
|
17.1 |
% |
Three Months Ended September 30, 2019 |
|
|
|
|
|
|
|
|||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
15.2 |
|
|
$ |
0.1 |
|
|
$ |
15.1 |
|
|
1.2 |
% |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
0.1 |
|
|
$ |
— |
|
|
0.1 |
|
|
|
|||
(Gains) losses from sale of assets and other |
0.4 |
|
|
2.3 |
|
|
(1.9) |
|
|
|
||||
Net income (loss) from ongoing operations |
$ |
15.7 |
|
|
$ |
2.4 |
|
|
$ |
13.3 |
|
|
15.3 |
% |
Nine Months Ended September 30, 2020 |
|
|
|
|
|
|
|
|||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
(31.6) |
|
|
$ |
(8.3) |
|
|
$ |
(23.3) |
|
|
26.3 |
% |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
0.1 |
|
|
— |
|
|
0.1 |
|
|
|
||||
(Gains) losses from sale of assets and other |
69.4 |
|
|
15.6 |
|
|
53.8 |
|
|
|
||||
Goodwill impairment |
13.7 |
|
|
3.2 |
|
|
10.5 |
|
|
|
||||
Net income (loss) from ongoing operations |
$ |
51.6 |
|
|
$ |
10.5 |
|
|
$ |
41.1 |
|
|
20.4 |
% |
Nine Months Ended September 30, 2019 |
|
|
|
|
|
|
|
|||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
68.0 |
|
|
$ |
10.5 |
|
|
$ |
57.5 |
|
|
15.4 |
% |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
0.6 |
|
|
$ |
0.1 |
|
|
0.5 |
|
|
|
|||
(Gains) losses from sale of assets and other |
(21.9) |
|
|
(1.5) |
|
|
(20.4) |
|
|
|
||||
Net income (loss) from ongoing operations |
$ |
46.7 |
|
|
$ |
9.1 |
|
|
$ |
37.6 |
|
|
19.5 |
% |
(g) |
On October 30, 2019, Bonnell Aluminum announced a rebranding initiative under which Bonnell and its subsidiaries, at that date, AACOA and Futura, would all operate under the Bonnell Aluminum brand. The usage of the AACOA and Futura trade names was discontinued at the end of 2019. In September 2019, management committed to implement the rebranding initiative. Prior to this commitment, the AACOA trade name had an indefinite useful life and a remaining net book value of |
|
Three Months Ended |
||||||||
($ in millions) |
September 30, 2019 |
|
December 31, 2019 |
||||||
AACOA - accelerated |
$ |
1.2 |
|
|
$ |
3.6 |
|
||
Futura - accelerated |
1.3 |
|
|
3.9 |
|
||||
Futura - ongoing1 |
0.1 |
|
|
0.1 |
|
||||
Total amortization |
$ |
2.6 |
|
|
$ |
7.6 |
|
||
1. Amortization based on original useful life. |